XLO · Xilio Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| GILEAD SCIENCES, INC. 10% Owner | ▲ Buy | Open Market | 9,105,451 Shares held | 12/18/2024 | View profile |
| Rene Russo PRESIDENT AND CEO | ▲ Buy | Option Exercise | 325,422 Shares held | 1/1/2026 | View profile |
| Katarina Luptakova CHIEF MEDICAL OFFICER | ▲ Buy | Option Exercise | 33,250 Shares held | 1/1/2026 | View profile |
| Christopher James Frankenfield Chief Financial Officer | ▼ Sell | Open Market | 24,766 Shares held | 1/2/2026 | View profile |
| James Samuel Shannon | ▲ Buy | Open Market | 10,000 Shares held | 3/26/2026 | View profile |
| Kevin M. Brennan SVP, FINANCE AND ACCOUNTING | ▼ Sell | Open Market | 6,371 Shares held | 1/2/2026 | View profile |
Transaction History
| James Samuel Shannon | ▲ Buy | Open Market | 5,000 | $44K | 3/26/2026 |
| Kevin M. Brennan | ▼ Sell | Open Market | 1,826 | $1K | 1/2/2026 |
| Christopher James Frankenfield | ▼ Sell | Open Market | 7,030 | $5K | 1/2/2026 |
| Katarina Luptakova | ▲ Buy | Option Exercise | 16,625 | — | 1/1/2026 |
| Kevin M. Brennan | ▲ Buy | Option Exercise | 5,000 | — | 1/1/2026 |
| Christopher James Frankenfield | ▲ Buy | Option Exercise | 19,375 | — | 1/1/2026 |
| Rene Russo | ▲ Buy | Option Exercise | 44,250 | — | 1/1/2026 |
| James Samuel Shannon | ▲ Buy | Open Market | 25,000 | $17K | 6/17/2025 |
| James Samuel Shannon | ▲ Buy | Open Market | 45,000 | $31K | 6/16/2025 |
| Rene Russo | ▲ Buy | Open Market | 36,289 | $25K | 6/16/2025 |
| Christopher James Frankenfield | ▼ Sell | Open Market | 6,954 | $7K | 1/2/2025 |
| Kevin M. Brennan | ▼ Sell | Open Market | 1,803 | $2K | 1/2/2025 |
| Katarina Luptakova | ▲ Buy | Option Exercise | 16,625 | — | 1/1/2025 |
| Christopher James Frankenfield | ▲ Buy | Option Exercise | 19,375 | — | 1/1/2025 |
| Kevin M. Brennan | ▲ Buy | Option Exercise | 5,000 | — | 1/1/2025 |
| Rene Russo | ▲ Buy | Option Exercise | 44,250 | — | 1/1/2025 |
| GILEAD SCIENCES, INC. | ▲ Buy | Open Market | 1,759,978 | $1.8M | 12/18/2024 |